ERNA CIK: 748592

Ernexa Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.5
FY22:
−21.0
FY23:
−20.4
FY24:
−15.8
FY25:
−7.02
Change from FY21 to FY25
millions USD
FY21:
−22.7
FY22:
−0.05
FY23:
−0.02
FY24:
−0.37
FY25:
−0.04
Change from FY21 to FY25
millions USD
FY21:
61.6
FY22:
19.6
FY23:
16.6
FY24:
6.26
FY25:
7.21
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.6
FY22:
−21.3
FY23:
−20.4
FY24:
−16.2
FY25:
−7.05

All amounts in millions USD Data source:SEC EDGAR